The United Laboratories International Holdings Limited

Informe acción SEHK:3933

Capitalización de mercado: HK$16.7b

Dividendos de United Laboratories International Holdings

Dividendo controles de criterios 2/6

United Laboratories International Holdings es una empresa que paga dividendos con una rentabilidad actual de 5.75% que está bien cubierta por los beneficios.

Información clave

6.1%

Rentabilidad por dividendo

27%

Ratio de pago

Rentabilidad media de la industria3.5%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendo17 Jun 24
Dividendo por acciónn/a
Beneficios por acciónHK$1.49
Rentabilidad por dividendo prevista a 3 años2.2%

Últimas actualizaciones de dividendos

Recent updates

Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

Feb 29
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

Jan 04
The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

Dec 14
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Nov 26
With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Aug 31
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

Aug 10
Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Dec 23
United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Oct 19
Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Aug 30
Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

Mar 08
Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

Feb 18
The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 03
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

Jan 19
Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

Jan 04
We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Dec 20
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

Dec 07
What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Nov 23
The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Próximo pago de dividendos

HoyApr 29 2024Fecha ex dividendoJun 17 20240Compra en los próximos 48 days para recibir el próximo dividendo0

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: 3933 lleva pagando dividendos menos de 10 años y durante este tiempo los pagos han sido volátiles.

Dividendo creciente: El pago de dividendos de 3933 ha aumentado, pero la empresa sólo ha pagado dividendos durante 6 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de United Laboratories International Holdings vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de 3933 con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (3933)6.1%
Suelo de mercado 25% (HK)3.3%
Techo de mercado 25% (HK)8.1%
Media de la industria (Pharmaceuticals)3.5%
Previsión de analistas en 3 años (3933)2.2%

Dividendo destacado: El dividendo de 3933(5.75%) es más alto que el 25% inferior de los pagadores de dividendos del mercado Hong Kong (3.39%).

Alto dividendo: El (5.75%) del dividendo de 3933 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.24%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (26.9%), los pagos de dividendos de 3933 están bien cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Datos insuficientes para calcular el ratio de pago en efectivo de 3933 para determinar si sus pagos de dividendos están cubiertos por los flujos de caja.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target